VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
immunosuppressive agent
Preclinical
Small molecule
S
Sun Yat-sen University
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Immunosuppressive Agents
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Immunosuppressive Agents
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Immunosuppressive Agents
1 trial
Multi-model Image of Immunosuppressive Agents in TAO
Unknown status
·
S
Sun Yat-sen University
·
N/A
·
NCT05110040
·
12 enrolled
Prevention
1 trial
ATG-F VS ATG for the Prevention of GVHD
Unknown status
·
F
Fujian Medical University
·
Phase 2/3
·
NCT03631563
·
120 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for immunosuppressive agent. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
immunosuppressive agent compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for immunosuppressive agent. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Sun Yat-sen University company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
S
Sun Yat-sen University
Related News